W. Reichert et al., 5 alpha-reductase in intact DU145 cells: Evidence for isozyme I and evaluation of novel inhibitors, ARCH PHARM, 333(7), 2000, pp. 201-204
The epithelial-like human prostatic carcinoma cell line DU145, which expres
ses 5 alpha-reductase type I isozyme, was used to test a series of potentia
l 5 alpha-reductase inhibitors. The exclusive expression of the type I isoz
yme was confirmed by PCR and subsequent DNA sequence analysis. Culture cond
itions were optimized for high conversion rates. Using this whole cell assa
y finasteride, 4MA, and 65 steroidal and non-steroidal compounds synthesize
d in our group were tested fur their inhibitory activity. Inhibitors with I
C50 values in the nanomolar range could be identified.